cimadronate has been researched along with ggti 286 in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (ggti 286) | Trials (ggti 286) | Recent Studies (post-2010) (ggti 286) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 25 | 0 | 7 |
| Protein | Taxonomy | cimadronate (IC50) | ggti 286 (IC50) |
|---|---|---|---|
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.6748 | |
| Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.017 | |
| Geranylgeranyl transferase type-1 subunit beta | Homo sapiens (human) | 1.0037 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, K; Iguchi, K; Nakano, T; Usui, S | 1 |
1 other study(ies) available for cimadronate and ggti 286
| Article | Year |
|---|---|
Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Topics: Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cytosol; Diphosphonates; Enzyme Inhibitors; Humans; Leucine; Male; Mevalonic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; rap1 GTP-Binding Proteins | 2006 |